A pretrained artificial intelligence model demonstrates a high sensitivity in detecting pancreatic cancer on CT scans, a new ...

A team of German scientists and biotech company Dynamic42 have jointly developed a ‘tumour-on-chip’ model of pancreatic ductal adenocarcinoma (PDAC), allowing insights into interactions ...

Scientists from the Terasaki Institute for Biomedical Innovation have recently designed an advanced pancreatic tumor model which more accurately depicts pancreatic ductal adenocarcinoma tumor ...

In major diabetes research news just published in Nature Communications, scientists at the Diabetes Research Institute (DRI) at the University of Miami have shown that a small peptide, called THR-123, ...

Pancreatic cancer happens when the DNA in the cells located in the pancreas mutate and start to grow uncontrollably to form a growth or tumor. ... The AI model was validated using over 1,470 CT exams.

Now, researchers are turning to an unexpected source for early PDAC detection: faecal samples. While analysing poo might seem an unlikely approach to cancer diagnosis, scientists are discovering that ...

Furthermore, this model allows for evaluating emerging treatments, including those designed to modulate pancreatic inflammation, fibrosis, and insulin production.

Pancreatic ductal adenocarcinoma (PDAC), is highly aggressive and lethal. It is the most prevalent type of pancreatic cancer, making up 90% of cases; it also has a high rate of metastasis, with an ...

A human cell model of pancreatic islets that closely replicates in vivo physiology opens up novel avenues for investigating the underlying mechanisms of diabetes,” she added.

Pancreatic ductal adenocarcinoma (PDAC) cancer has a “dismal” survival rate, the authors noted, and is predicted to become the second most lethal cancer by 2030.

A team of German scientists and biotech company Dynamic42 have jointly developed a ‘tumour-on-chip’ model of pancreatic ductal adenocarcinoma (PDAC), allowing insights into interactions ...